To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours

J Am Heart Assoc. 2022 Oct 4;11(19):e027238. doi: 10.1161/JAHA.122.027238. Epub 2022 Sep 21.
No abstract available

Keywords: Editorials; anticoagulants; ischemic stroke; tissue plasminogen activator.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Brain Ischemia* / chemically induced
  • Brain Ischemia* / drug therapy
  • Fibrinolytic Agents
  • Humans
  • Ischemic Stroke* / drug therapy
  • Stroke* / chemically induced
  • Stroke* / drug therapy
  • Thrombolytic Therapy / adverse effects
  • Tissue Plasminogen Activator
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator